WallStreetZenWallStreetZen

NASDAQ: PMCB
Pharmacyte Biotech Inc Stock Ownership - Who owns Pharmacyte Biotech?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pharmacyte Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua SilvermanCEO and President2026-01-0740,000$0.83
$33.32kBuy
Jonathan SchechterDirector2026-01-0720,000$0.84
$16.88kBuy
Joshua SilvermanCEO and President2026-01-0630,000$0.79
$23.67kBuy
Jonathan SchechterDirector2026-01-0620,000$0.79
$15.80kBuy
Joshua SilvermanCEO and President2026-01-0530,000$0.78
$23.49kBuy
Jonathan SchechterDirector2026-01-0520,000$0.78
$15.56kBuy
Robert 1. WeinsteinDirector2025-12-1233,750$1.02
$34.43kSell
Jonathan SchechterDirector2025-12-1267,500$1.02
$68.85kSell
Joshua SilvermanCEO and President2025-12-12258,750$1.02
$263.93kSell
Wayne Remell WalkerDirector2025-12-1216,875$1.02
$17.21kSell

1 of 2

PMCB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMCB insiders and whales buy or sell their stock.

PMCB Shareholders

What type of owners hold Pharmacyte Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Daniel Stuart Farb6.66%714,570$543.79kInsider
Joshua Silverman4.34%466,250$354.82kInsider
Citadel Advisors LLC3.35%359,547$273.62kInstitution
Daniel Allen2.42%260,000$197.86kInsider
Geode Capital Management LLC1.82%195,660$148.90kInstitution
Jonathan Schechter1.79%192,500$146.49kInsider
Renaissance Technologies LLC0.53%56,500$43.00kInstitution
Xtx Topco Ltd0.49%52,362$39.85kInstitution
Vanguard Capital Management LLC0.48%51,467$39.17kInstitution
Robert 1. Weinstein0.38%41,250$31.39kInsider

1 of 3

PMCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMCB9.01%16.46%Net Selling
CELZ2.62%0.95%
IMNN5.50%94.50%Net BuyingNet Buying
APRE3.64%96.36%Net Buying
HCWB6.68%15.92%Net BuyingNet Buying
View Top Biotech Stocks

Pharmacyte Biotech Stock Ownership FAQ

Who owns Pharmacyte Biotech?

Pharmacyte Biotech (NASDAQ: PMCB) is owned by 9.01% institutional shareholders, 16.46% Pharmacyte Biotech insiders, and 74.53% retail investors. Daniel Stuart Farb is the largest individual Pharmacyte Biotech shareholder, owning 714,570.00 shares representing 6.66% of the company. Daniel Stuart Farb's Pharmacyte Biotech shares are currently valued at $543.79k.

If you're new to stock investing, here's how to buy Pharmacyte Biotech stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.